Synthetic cathinones: Chemical phylogeny, physiology, and neuropharmacology

Life Sciences

Volumn 97, Issue 1, 2014, Pages 20-26

  De Felice, Louis J ^a   Glennon, Richard A ^b   Negus, Sidney S ^c  

^a SCHOOL OF MEDICINE   (United States)

^b School of Pharmacy   (United States)

^c VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

Amphetamine; Bath salts; Cocaine; Dopamine; Intracranial selfstimulation (ICSS); MDPV; Mephedrone; Methamphamine; Methcathinone; Methylone; Serotonin; Synthetic cathinones; Transporters

Indexed keywords

AMPHETAMINE; BATH SALTS; COCAINE; DOPAMINE; INTRACRANIAL SELFSTIMULATION (ICSS); MDPV; MEPHEDRONE; METHAMPHAMINE; METHCATHINONE; METHYLONE; SEROTONIN; SYNTHETIC CATHINONES; TRANSPORTERS;

ALKALOIDS; ANIMALS; BEHAVIOR, ANIMAL; BENZODIOXOLES; DESIGNER DRUGS; HUMANS; PYRROLIDINES; RATS; SUBSTANCE-RELATED DISORDERS;

EID: 84894051965     PISSN: 00243205     EISSN: 18790631     Source Type: Journal    
DOI: 10.1016/j.lfs.2013.10.029     Document Type: Review

References (61)

1. G.A. Alles, M.D. Fairchild, and M. Jensen Chemical pharmacology of Catha edulis J Med Pharm Chem 3 1961 323 352
2. C.T. BAuer, M.L. BAnks, B.E. Blough, and S.S. Negus Use of intracranial self-stimulation to evaluate abuse-related and abuse-limiting effects of monoamine releasers in rats Br J Pharmacol 168 4 2013 850 862
3. M.H. Baumann, J.S. Partilla, K.R. Lehner, E.B. Thorndike, A.F. Hoffman, and M. Holy et al. Powerful cocaine-like actions of 3,4- methylenedioxypyrovalerone (MDPV), a principal constituent of psychoactive 'bath salts' products Neuropsychopharmacology 2012 10.1038/npp.2012.204
4. M.H. Baumann, M.A. Ayestas Jr, J.S. Partilla, J.R. Sink, A.T. Shulgin, and P.F. Daley et al. The designer methcathinone analogs, mephedrone and methylone, are substrates for monoamine transporters in brain tissue Neuropsychopharmacology 37 5 2012 1192 1203
5. M.H. Baumann, J.S. Partilla, K.R. Lehner, E.B. Thorndike, A.F. Hoffman, and M. Holy et al. Powerful cocaine-like actions of 3,4- Methylenedioxypyrovalerone (MDPV), a principal constituent of psychoactive 'bath salts' products Neuropsychopharmacology 38 4 2013 552 562
6. J.S. Bonano, R.A. Glennon, L.J. De Felice, M.L. Banks, and S.S. Negus Abuse-related and abuse-limiting effects of methcathinone and the synthetic "bath salts" cathinone analogs methylenedioxypyrovalerone (MDPV), methylone and mephedrone on intracranial self-stimulation in rats Psychopharmacology (Berl) 2013 [in press] (2013)
7. K.N. Cameron, R. Kolanos, R. Verkariya, L. De Felice, and R.A. Glennon Mephedrone and methylenedioxypyrovalerone (MDPV), major constituents of "bath salts," produce opposite effects at the human dopamine transporter Psychopharmacology (Berl) 227 2013 493 499
8. K.N. Cameron, R. Kolanos, E. Solis Jr, R.A. Glennon, and L. De Felice Bath salts components mephedrone and methylenedioxypyrovalerone (MDPV) act synergistically at the human dopamine transporter Br J Pharmacol 168 2013 1750 1757
9. W.A. Carlezon Jr., and E.H. Chartoff Intracranial self-stimulation (ICSS) in rodents to study the neurobiology of motivation Nat Protoc 2 11 2007 2987 2995
10. L. Carvelli, R.D. Blakely, and L.J. De Felice Dopamine transporter/syntaxin 1A interactions regulate transporter channel activity and dopaminergic synaptic transmission Proc Natl Acad Sci U S A 105 37 2008 14192 14197
11. N.V. Cozzi, S.D. Brandt, P.F. Daley, J.S. Partilla, R.B. Rothman, and A. Tulzer et al. Pharmacological examination of trifluoromethyl ring-substituted methcathinone analogs Eur J Pharmacol 699 1-3 2013 180 187
12. D.P. Daberkow, H.D. Brown, K.D. Bunner, S.A. Kraniotis, M.A. Doellman, and M.E. Ragozzino et al. Amphetamine paradoxically augments exocytotic dopamine release and phasic dopamine signals J Neurosci 33 2 2013 452 463
13. T.A. Dal Cason, R. Young, and R.A. Glennon Cathinone: an investigation of several N-alkyl and methylenedioxy-substituted analogs Pharmacol Biochem Behav 58 1997 1109 1116 (Pubitemid 28108223)
14. DEA Operation Somalia express: largest khat enforcement eve News Release 2006 [ http://www.justice.gov/dea/pubs/pressrel/pr072606p.html ]
15. L.J. DeFelice, and T. Goswami Transporters as channels Annu Rev Physiol 69 2007 87 112 (Pubitemid 46457637)
16. U.N. Document The botany and chemistry of khat MNAR: GE.79-10365 1979
17. Document, U. N Studies on the chemical composition of khat. III Investigations on the phenylalkylamine fraction MNAR: GE.75-12624 1975
18. S.M. Florin, R. Kuczenski, and D.S. Segal Effects of reserpine on extracellular caudate dopamine and hippocampus norepinephrine responses to amphetamine and cocaine: mechanistic and behavioral considerations J Pharmacol Exp Ther 274 1 1995 231 241
19. H. Friebel, and R. Brilla Über den zentralerregenden Wirkstoff der frischen Blätter und Zweigspitzen von Catha edulis Naturwissenschaften 50 1963 354 355
20. T. Fuwa, N. Fukumori, T. Tanaka, Y. Kuboo, A. Ogata, and S. Uehara et al. Microdialysis study of drug effects on central nervous system: changes of dopamine levels in mice striatum after oral administration of methylenedioxypyrovalerone Ann. Rep. Tokyo Metr. Inst. P. H 58 2007 287 292
21. R.A. Glennon, and D. Showalter The effect of cathinone and several related derivatives on locomotor activity Res Commun Subst Abus 2 1981 186 191
22. R.A. Glennon, M.D. Schechter, and J.A. Rosecrans Discriminative stimulus properties of S(-)- and R(+)-cathinone, (+)cathine, and several structural modifications Pharmacol Biochem Behav 21 1984 1 3 (Pubitemid 14085586)
23. R.A. Glennon, R. Young, A.E. Hauck, and J.D. Mckenney Structure-activity studies on amphetamine analogs using drug discrimination methodology Pharmacol Biochem Behav 21 6 1984 895 901 (Pubitemid 15150742)
24. R.A. Glennon, M. Yousif, N.A. Naiman, and P. Kalix Methcathinone: a new and potent amphetamine-like agent Pharmacol Biochem Behav 26 1987 547
25. R.A. Glennon, R. Young, B.R. Martin, and T.A. Dal Cason Methcathinone ("CAT"): an enantiomeric potency comparison Pharmacol Biochem Behav 50 1995 601 606
26. J.F. Hyde, E. Browning, and R. Adams Synthetic homologs of d,l-ephedrine J Am Chem Soc 50 1928 2287 2292
27. C.M. Hysek, L.D. Simmler, V.G. Nicola, N. Vischer, M. Donzelli, and S. Krähenbühl et al. Duloxetine inhibits effects of MDMA ("ecstasy") in vitro and in humans in a randomized placebo-controlled laboratory study PloS ONE 7 5 2012 e36476
28. ICE Thirteen members of international khat trafficking ring convicted News Release 2012 [ http://www.justice.gov/dea/pubs/pressrel/pr072606p.html ]
29. S.L. Ingram, B.M. Prasad, and S.G. Amara Dopamine transporter-mediated conductances increase excitability of midbrain dopamine neurons Nat Neurosci 5 10 2002 971 978
30. L.E. Iversen A report submitted to the Home Secretary of the UK Consideration of the cathinones. Advisory Council on the Misuse of Drugs 2010 [March 31]
31. L. Iversen Consideration of the cathinones, Advisory Council on the Misuse of Drugs (ACMD) 2010
32. Jacob P, Shulgin AT. Novel N-substituted 2-amino-3′,4′- methylenedioxy-propiophenone. WO Patent 9639133, 1996.
33. P. Kalix A constituent of khat leaves with amphetamine-like releasing properties Eur J Pharmacol 68 1980 213 215 (Pubitemid 11253819)
34. P. Kalix, and R.A. Glennon Further evidence for an amphetamine-like mechanism of action of the alkaloid cathinone Biochem Pharmacol 35 1986 3015 3019 (Pubitemid 16014693)
35. J. Knoll Studies on the central effects of (-)cathinone NIDA Res Monogr 27 1979 322 323
36. Köppe H, Ludwig G, et al. "1-(3′,4′-Methylenedioxy- phenyl-2-pyrrlidino-alkanones-(1)." US Patent 3,478,050, 1969.
37. L'Italien YJ, Park H, Rebstock LC. Methylaminopropiophenone compounds and methods for producing the same. US Patent 2,802,865,1957.
38. L.J. Marinetti, and H.M. Antonides Analysis of synthetic cathinones commonly found in bath salts in human performance and postmortem toxicology: method development, drug distribution and interpretation of results J Anal Toxicol 37 3 2013 135 146
39. R.J. Naftalin, and L.J. De Felice Transporters and co-transporters in theory and practice to appear [published by] Comprehensive biophysics 2011 Elsevier Press
40. Ramsson E, Howard C, Covey, DP, Garris PA. High doses of amphetamine augment, rather than disrupt, exocytotic dopamine release in the dorsal and ventral striatum of the anesthetized rat. J Neurochem 119: 1162-1172.
41. S. Ristic, and A. Thomas On the constituents of Catha edulis Arch Pharm 295 1962 524 525
42. J.A. Rosecrans, O.L. Campbell, W.L. Dewey, and L.S. Harris Discriminative stimulus and neurochemical mechanism of cathinone: a preliminary study NIDA Res Monogr 27 1979 328 329
43. M.B. Rosenberg, F.I. Carroll, and S.S. Negus Effects of monoamine reuptake inhibitors in assays of acute pain-stimulated and pain-depressed behavior in rats J Pain 14 2013 246 249 [PMCID: PMC3743421]
44. V.G. Savenko, E.P. Semkin, V.I. Sorokin, and S.P. Kasankov Expert examination of narcotic substances obtained from ephedrine U. M. o. t. Interior, All-Union Scientific Research Institute Report 1989 1 22
45. M.D. Schechter, and R.A. Glennon Cathinone, cocaine and methamphetamine: similarity of behavioral effects Pharmacol Biochem Behav 22 1985 913 916 (Pubitemid 15033461)
46. K.G. Shanks, T. Dahn, G. Behonick, and A. Terrel Analysis of first and second generation legal highs for synthetic cannabinoids and synthetic stimulants by ultra-performance liquid chromatography and time of flight mass spectrometry J Anal Toxicol 36 6 2012 360 371
47. L.D. Simmler, T.A. Buser, M. Donzelli, Y. Schramm, L.H. Dieu, and J. Huwyler et al. Pharmacological characterization of designer cathinones in vitro Br J Pharmacol 168 2 2013 458 470
48. H.A. Spiller, M.L. Ryan, R.G. Weston, and J. Jansen Clinical experience with and analytical confirmation of 'bath salts' and 'legal highs' (synthetic cathinones) in the United States Clin Toxicol 49 2011 499 505
49. D. Sulzer How addictive drugs disrupt presynaptic dopamine neurotransmission Neuron 69 2012 628 649
50. D. Sulzer, and A. Galli Dopamine transport currents are promoted from curiosity to physiology Trends Neurosci 26 4 2003 173 176 (Pubitemid 36411996)
51. D. Sulzer, N.T. Maidment, and S. Rayport Amphetamine and other weak bases act to promote reverse transport of dopamine in ventral midbrain neurons J Neurochem 60 2 1993 527 535 (Pubitemid 23030947)
52. D. Sulzer, T.K. Chen, Y.Y. Lau, H. Kristensen, S. Rayport, and A. Ewing Amphetamine redistributes dopamine from synaptic vesicles to the cytosol and promotes reverse transport J Neurosci 15 5 Pt 2 1995 4102 4108
53. D. Sulzer, and M.S. Sonders et al. Mechanisms of neurotransmitter release by amphetamines: a review Prog Neurobiol 75 6 2005 406 433 (Pubitemid 40834286)
54. UNODC The challenge of new psychoactive substances 2013 United Nations Office on Drugs and Crime Vienna, Austria 1 108
55. J.B. van der Schoot, E.J. Ariens, J.M. van Rossum, and J.A.T.M. Hurkmans Phenylisopropylamine derivatives, structure and action Arzneimittelforschung 12 1962 902 907
56. S. Vlachou, and A. Markou Intracranial self-stimulation Animal models of drug addiction 2011 Humana Press New York
57. B.H. Westerink, J. Tuntler, G. Damsma, H. Rollema, and J.B. de Vries The use of tetrodotoxin for the characterization of drug-enhanced dopamine release in conscious rats studied by brain dialysis Naunyn-Schmiedeberg's Arch Pharmacol 336 5 1987 502 507 (Pubitemid 17166839)
58. B.H. Westerink, G. Damsma, and J.B. de Vries Effect of ouabain applied by intrastriatal microdialysis on the in vivo release of dopamine, acetylcholine, and amino acids in the brain of conscious rats J Neurochem 52 3 1989 705 712 (Pubitemid 19067525)
59. O. Wolfes Über das Vorkommen von d-nor-iso-Ephedrine in Catha edulis Arch Pharm 268 1930 81 83
60. T. Yanagita Studies on cathinones: cardiovascular and behavioral effects in rats and self-administration experiment in Rhesus monkeys NIDA Res Monogr 27 1979 326 327
61. K.Y. Zhingel, W. Dovensky, A. Crossman, and A. Allen Ephedrone: 2-methylamino-1-phenylpropan-1-one (Jeff) J Forensic Sci 36 1990 915 922